Pharmaceutical Executive-03-01-2013

Pharmaceutical Executive

Pharm Exec's 35-member Editorial Advisory Board met last month to discuss a range of topics, including the influence of other business sectors on pharma's global strategy.

Pharmaceutical Executive
Columns

March 01, 2013

What can happen when reps focus on the physician-patient conversation? Al Topin reports.

Pharmaceutical Executive

S

Pharmaceutical Executive

Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.

Ken Getz of the Tufts University Center for the Study of Drug Development (CSDD) explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.

Innovation in hub program design for patient scrip data and clinical support services can lead to increased market share in the hotly contested specialty medicine space.

Pharmaceutical Executive

Chinese policies are to pose new opportunities and challenges for Big Pharma companies active in the country.

Pharmaceutical Executive

A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.

Pharmaceutical Executive
Columns

March 01, 2013

Pressure for action on key enforcement and regulatory issues may prompt congressional action this year.

Pharmaceutical Executive

European Commision blocks the authorization of a life-saving liver drug outside of France.

Pharmaceutical Executive
Features

March 01, 2013

In 2012, Merck's diabetes franchise became the highest-selling product family in its 122-year history.

Pharmaceutical Executive

Timely engagement is the key to expanding the use of companion diagnostics.

Pharmaceutical Executive

Big Pharma takes a fresh licking in our latest audit of US press coverage of business and policy issues.

Pharmaceutical Executive

As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property.

Pharmaceutical Executive

Do terminally ill patients have a right to try unapproved, investigational drugs? Ben Comer reports.

Pharmaceutical Executive
Country Report

March 01, 2013

China's pharmaceutical industry is making record gains. Four years ago, China was the world's fifth largest market. Now, it has bypassed France and Germany to become the third largest. By 2015, China will pass Japan to rival only the United States for number one.